[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100596125":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":52,"collaborators":25,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":25,"eligibilityCriteria":60,"healthyVolunteers":57,"sex":61,"minAge":62,"maxAge":63,"enrollmentInfo":64,"targetDuration":25,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":25,"overallStatus":73,"whyStopped":25,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Shalamar Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A","EXPERIMENTAL","Group A: 75 mg aspirin nightly.",[13],"Drug: Aspirin 75 mg",{"label":15,"type":10,"description":16,"interventionNames":17},"Group B","Group B: 150 mg aspirin nightly.",[18],"Drug: Aspirin 150 mg",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Aspirin 75 mg","This study aims to evaluate the effectiveness of 75 mg aspirin versus 150 mg aspirin in preventing preeclampsia among individuals with high risk for the condition.\n\nEligible women attending the antenatal clinic were screened by history, physical exam, and uterine artery Doppler. Risk assessment was entered into the Fetal Medicine Foundation software. Participants were randomized:\n\nGroup A: 75 mg aspirin nightly. Group B: 150 mg aspirin nightly.",[9],null,{"type":21,"name":27,"description":23,"armGroupLabels":28,"otherNames":25},"Aspirin 150 mg",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Dr. Hafiz Wajahat Naseem Naseem, M.B.B.S","CONTACT","+923237435943","wnaseem60@gmail.com",[36],{"facility":5,"status":25,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Lahore","Punjab Province","54000","Pakistan","PK",{"type":43,"coordinates":44},"Point",[45,46],74.35071,31.558,{"lat":46,"lon":45},[49,50],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},{"name":31,"role":51,"phone":25,"phoneExt":25,"email":25},"PRINCIPAL_INVESTIGATOR",{"type":51,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Hafiz Wajahat Naseem","Post Graduate Resident in Gynae and OBS. Department","100596125","comparing-the-efficacy-of-75mg-versus-150mg-aspirin-for-the-prevention-of-preeclampsia-in-high-risk-pregnant-women-100596125",false,"NCT07041385","Comparing the Efficacy of 75mg Versus 150mg Aspirin for the Prevention of Preeclampsia in High-Risk Pregnant Women","Inclusion Criteria:\n\n1. Screen positive women\n2. Age 18 - 30 y\n3. Gestational Age 11 - 13+6 weeks\n4. Singleton Pregnancy\n5. Estimated risk for preterm PE of \\> 1 in 100 (Reference - Fetal Medicine Foundation)\n\nExclusion Criteria:\n\n1. Screen negative women\n2. Age \\> 30 y\n3. Gestational Age \\> 14 weeks\n4. Multiple Gestation\n5. Estimated risk for preterm PE of \\\u003C 1 in 100 (Reference - Fetal Medicine Foundation)","FEMALE","18 Years","30 Years",{"count":65,"type":66},340,"ESTIMATED","INTERVENTIONAL",[69],"NA","This study aims to evaluate the effectiveness of 75 mg aspirin versus 150 mg aspirin in preventing preeclampsia among individuals with high risk for the condition. Existing literature suggests that the 150 mg aspirin dose may exhibit superior efficacy, yet inconclusive evidence exists in our local setting.",[72],"Preeclampsia (PE)","NOT_YET_RECRUITING","2025-10-02",{"date":76,"type":77},"2025-10-08","ACTUAL",{"date":79,"type":66},"2025-11-01",{"date":81,"type":66},"2027-06-30",{"name":5,"class":6},1]